SE0000718D0 - New use - Google Patents
New useInfo
- Publication number
- SE0000718D0 SE0000718D0 SE0000718A SE0000718A SE0000718D0 SE 0000718 D0 SE0000718 D0 SE 0000718D0 SE 0000718 A SE0000718 A SE 0000718A SE 0000718 A SE0000718 A SE 0000718A SE 0000718 D0 SE0000718 D0 SE 0000718D0
- Authority
- SE
- Sweden
- Prior art keywords
- target polypeptide
- glucose
- prevention
- identifying
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a method for identifying an agent useful for the treatment or prevention of a medical condition related to reduced cellular uptake of glucose, said method comprising the steps of: (i) identifying a target polypeptide interacting with the compound U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene); (ii) contacting a candidate agent with the said target polypeptide; and (iii) determining whether said candidate agent modulates the biological activities of the said target polypeptide, such modulation being indicative for an agent useful for the treatment or prevention of a medical condition related to reduced cellular uptake of glucose.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000718A SE0000718D0 (en) | 2000-03-03 | 2000-03-03 | New use |
US09/797,227 US20010019832A1 (en) | 2000-03-03 | 2001-03-01 | Methods for identification using U0126 |
JP2001563106A JP2003525431A (en) | 2000-03-03 | 2001-03-02 | Method for identifying a medicament for treating NIDDM-diabetes by interacting with compound U0126 |
CA002399889A CA2399889A1 (en) | 2000-03-03 | 2001-03-02 | Method for identifying an agent for treatment of niddm diabetes by interaction with compound u0126 |
EP01912628A EP1259232A1 (en) | 2000-03-03 | 2001-03-02 | Method for identifying an agent for treatment of niddmdiabetes by interaction with compound u0126 |
PCT/SE2001/000450 WO2001064209A1 (en) | 2000-03-03 | 2001-03-02 | Method for identifying an agent for treatment of niddmdiabetes by interaction with compound u0126 |
AU2001241316A AU2001241316A1 (en) | 2000-03-03 | 2001-03-02 | Method for identifying an agent for treatment of niddmdiabetes by interaction with compound u0126 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000718A SE0000718D0 (en) | 2000-03-03 | 2000-03-03 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0000718D0 true SE0000718D0 (en) | 2000-03-03 |
Family
ID=20278690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0000718A SE0000718D0 (en) | 2000-03-03 | 2000-03-03 | New use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1259232A1 (en) |
JP (1) | JP2003525431A (en) |
AU (1) | AU2001241316A1 (en) |
CA (1) | CA2399889A1 (en) |
SE (1) | SE0000718D0 (en) |
WO (1) | WO2001064209A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE212552T1 (en) * | 1998-04-17 | 2002-02-15 | Tufts College | MAP KINASE INHIBITORS FOR THE TREATMENT OF TNF-ALPHA INDUCED LIPOLYSIS CAUSED DISEASES |
-
2000
- 2000-03-03 SE SE0000718A patent/SE0000718D0/en unknown
-
2001
- 2001-03-02 CA CA002399889A patent/CA2399889A1/en not_active Abandoned
- 2001-03-02 EP EP01912628A patent/EP1259232A1/en not_active Withdrawn
- 2001-03-02 WO PCT/SE2001/000450 patent/WO2001064209A1/en not_active Application Discontinuation
- 2001-03-02 JP JP2001563106A patent/JP2003525431A/en active Pending
- 2001-03-02 AU AU2001241316A patent/AU2001241316A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001241316A1 (en) | 2001-09-12 |
EP1259232A1 (en) | 2002-11-27 |
WO2001064209A1 (en) | 2001-09-07 |
CA2399889A1 (en) | 2001-09-07 |
JP2003525431A (en) | 2003-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9808348A (en) | Medicinal food for diabetics | |
NO20011351L (en) | Method of treating diabetes using an AP2 inhibitor and combination thereof | |
EA200200105A1 (en) | Compounds modulating PPARγ activity; | |
BR0116370A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient. | |
CY1109062T1 (en) | METHODS OF DETERMINING AND ANTI-VASCULAR Suspension | |
ATE324106T1 (en) | COMPOSITIONS AND METHODS FOR REGULATING SERUM CHOLESTEROL | |
TW200505829A (en) | Protease inhibitors for coronaviruses and sars-cov and the use thereof | |
BR9815469A (en) | Protease inhibitors | |
BR9913190A (en) | Modulation of multiple lineage protein kinase | |
BR9813996A (en) | 2-arylbenzo [b] thiophenes useful for the treatment of estrogen deprivation syndrome | |
ATE383870T1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES WITH GPR49 | |
DE60231969D1 (en) | sPLA2-INHIBITORS FOR THE TREATMENT OF ARTERIOSCLEROSIS | |
PT1147420E (en) | URINARY TRYSPIN INHIBITOR FOR AIDS DIAGNOSIS | |
SE0000718D0 (en) | New use | |
GB9930768D0 (en) | Composition | |
WO2004109290A3 (en) | Methods for identifying modulators of kinesin activity | |
DE69905489D1 (en) | PROTEIN C FOR THE TREATMENT OF SICKLE LEMENIA AND THALASSEMIA | |
DE69925301D1 (en) | COMPOSITION OF RILUZOLE AND ALPHA-TOCOPHEROL | |
AU2003211660A1 (en) | Sumo inhibitors | |
WO2005075632A3 (en) | Treatment of neurodegenerative diseases by the use of atp7a-modulators | |
ATE362545T1 (en) | SCREENING PROCEDURE FOR SUBSTANCES FOR THE TREATMENT OF DIABETES | |
CY1110278T1 (en) | A METHOD OF DIAGNOSTING FACTORS TO Cure OBESITY | |
WO2002024204A3 (en) | Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter | |
DK1366033T3 (en) | Chemical compounds | |
BR9807920A (en) | Processes for treating dementia in a subject and for preventing dementia |